Background The Joint Committee on Vaccination and Immunisation in the United Kingdom
requested an evidence synthesis to investigate the relationship between asthma and …

Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and
asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of …

Chronic Obstructive Pulmonary Disease (COPD) is a progressive pulmonary disorder
underpinned by poorly reversible airflow resulting from chronic bronchitis or emphysema …

Early in the COVID pandemic there were concerns about the outcomes for patients with
COPD who developed COVID-19. Although the pandemic has made the diagnosis and …

Background: Severe coronavirus disease 2019 (COVID-19) can boost the systematic
inflammatory response in critically ill patients, causing a systemic hyperinflammatory state …

Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience |
European Respiratory Society Skip to main content Main menu Home Current issue Early …

The influence of inhaled corticosteroids (ICS) on COVID-19 outcomes remains uncertain. To
address this, we conducted a systematic review and meta-analysis, analyzing 30 studies, to …

Inhaled corticosteroids (ICS) have been associated with increased risk of pneumonia. Their
impact on respiratory virus infections is unclear. We performed a post-hoc analysis of the …

Background There is conflicting evidence regarding the effect of asthma and its different
therapeutic options on COVID-19 severity and the clinical outcomes. Aim This study aimed …

Summary The Austrian Society of Pneumology (ASP) launched a first statement on severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time …